European Medical Solutions
ALEMS | BR
Overview
Corporate Details
- ISIN(s):
- BE0974289218 (+1 more)
- LEI:
- 549300S8FE7T7B105H72
- Country:
- Belgium
- Address:
- RUE DES CHASSEURS ARDENNAIS 7, 4031 ANGLEUR
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
The DMS Group is composed of companies with a strong innovative potential. Foremost focused on the medical imaging industry, it is aimed to extend to new horizons these last few years. By orienting its strategy toward the future and investing in R&D, the Group aims to bring out tomorrow’s solutions. DMS Group is present on all continents through a network of more than 140 national distributors, subsidiaries, and joint ventures. DMS Group is quoted on the Euronext Growth market in Paris (ALDMS).
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-22 08:00 |
Earnings Release
CP_22_04_2025_EMS_CA T1 2025.pdf
|
French | 268.3 KB | |
| 2025-04-14 18:00 |
Earnings Release
EMS GROUP : ANNUAL RESULTS 2024 - SUSTAINED GROWTH AND STRONG IMPROVEMENT IN OP…
|
English | 495.3 KB | |
| 2025-04-14 18:00 |
Earnings Release
EMS : RÉSULTATS ANNUELS 2024 - CROISSANCE SOUTENUE ET FORTE AMÉLIORATION DE LA …
|
French | 470.4 KB | |
| 2025-04-14 18:00 |
Earnings Release
CP_14_04_2025_EMS_annual_results_2024_EN.pdf
|
English | 495.3 KB | |
| 2025-04-14 18:00 |
Earnings Release
CP_14_04_2025_EMS_resultats_annuels_2024.pdf
|
French | 470.4 KB | |
| 2025-04-14 18:00 |
Annual Report
EMS - 2024 Rapport annuel.pdf
|
French | 2.9 MB | |
| 2025-01-16 17:45 |
Earnings Release
CP_16_01_2025_EMS - CA 2024.pdf
|
French | 196.3 KB | |
| 2024-12-20 08:00 |
Regulatory News Service
CP_20_12_2024_EMS - Regroupement d'actions.pdf
|
French | 164.5 KB | |
| 2024-12-20 08:00 |
Regulatory News Service
EMS : MISE EN OEUVRE DU REGROUPEMENT D'ACTIONS
|
French | 164.5 KB | |
| 2024-10-17 18:00 |
Earnings Release
CHIFFRE D'AFFAIRES DU 3ÈME TRIMESTRE 2024 : EMS POURSUIT SA CROISSANCE
|
French | 195.1 KB | |
| 2024-10-07 18:00 |
Earnings Release
CP_07_10_2024_EMS - Re´sultats 1er semestre 2024.pdf
|
French | 287.1 KB | |
| 2024-10-07 18:00 |
Interim Report
2024.06-Rapport-semestriel-EMS.pdf
|
French | 567.2 KB | |
| 2024-10-07 18:00 |
Earnings Release
EMS : CROISSANCE ET INNOVATION AU 1ER SEMESTRE 2024
|
French | 287.1 KB | |
| 2024-07-18 17:45 |
Earnings Release
EUROPEAN MEDICAL SOLUTIONS ( ex DMS Imaging) : Chiffre d'affaires du 1er semest…
|
French | 175.0 KB | |
| 2024-06-27 08:00 |
Regulatory News Service
Annexes PV AGE _04474755.pdf
|
French | 2.5 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2019-12-06 | ESPAD SERVICES SA | Close relation | Sell | 21,000 | 6,156.00 EUR |
| 2019-12-05 | ESPAD SERVICES SA | Close relation | Sell | 22,000 | 8,202.00 EUR |
| 2019-12-04 | ESPAD SErvices SA | Close relation | Sell | 43,000 | 11,815.00 EUR |
| 2019-11-26 | Désiront Yves | Board | Sell | 77,543 | 29,466.34 EUR |
| 2019-11-26 | Ghem Philippe | Executive member | Sell | 25,000 | 7,500.00 EUR |
| 2019-08-19 | van der Straten Everard | Close relation | Buy | 1,000 | 1,060.00 EUR |
| 2019-08-16 | Ghem Philippe | Executive member | Buy | 5,000 | 5,412.00 EUR |
| 2019-06-05 | Désiront Yves | Close relation | Buy | 12,243 | 15,641.66 EUR |
| 2019-06-03 | Désiront Yves | Close relation | Buy | 20,000 | 24,880.00 EUR |
| 2019-04-05 | Désiront Yves | Close relation | Buy | 15,000 | 24,096.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |